Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 60

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 60
---
 The net
tangible book value of our Common Stock on September 30, 2025 was approximately $ 3.3 million, or approximately $0.06 per share. Net
tangible book value per share is equal to the amount of our total tangible assets, less total liabilities, divided by the aggregate number
of shares of our Common Stock outstanding.

After giving effect to the assumed sale by
us of 3,125,000 shares underlying the Units (assuming the sale of all securities offered hereby, at the fixed public offering price of
$3.20 per Unit, and assuming no exercise of the IPO Warrants issued in connection with this offering), our as adjusted net tangible book
value as of September 30, 2025 would have been approximately $7.7 million, or approximately $0.12 per share. This represents an immediate
increase in net tangible book value of approximately $0.06 per share to existing stockholders and an immediate dilution of approximately
$3.08 per share to new investors purchasing Units in this offering. The following table illustrates this per share dilution:

| Assumed initial public offering price per Unit                                                    |     |   |      |     | $ | 3.20 |
| Historical                                                                                        
 net tangible book value per share as of September 30, 2025                                        |     | $ | 0.06 |     |   |      |
| Increase                                                                                          
 in net tangible book value per share attributable to new investors participating in this offering |     | $ | 0.06 |     |   |      |
| Pro                                                                                               
 forma as adjusted net tangible book value per share after this offering                           |     |   |      |     | $ | 0.12 |
| Dilution                                                                                          
 per share to new investors participating in this offering                                         |     |   |      |     | $ | 3.08 |

The foregoing discussion and table does not take
into account further dilution to investors in this offering that could occur upon the exercise of outstanding options and warrants having
a per share exercise price less than the public offering price per share in this Primary Offering.

<div align='center'>34

MARKET PRICE OF AND DIVIDENDS ON THE COMPANY’S

COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</div>

Market Information

Our Common Stock is quoted on the OTCID tier
of the OTC Market under the symbol “RVRC”. Over-the-counter market quotations reflect inter-dealer prices, without